NCT01791218

Surgical Pulmonary Vein Isolation Efficiency Study

Concomitant Pulmonary Vein Isolation in Treatment of Paroxysmal Atrial Fibrillation Patients Undergoing Elective Coronary Artery Bypass Grafting and Aortic Valve Replacement for Aortic Stenosis: a Prospective Study

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: Kuopio University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

A substantial proportion of patients undergoing elective coronary artery bypass grafting have a history of paroxysmal atrial fibrillation. Paroxysmal atrial fibrillation has adverse short-and long term postoperative effects. Pulmonary vein isolation (PVI) seems to be effective treatment for paroxysmal atrial fibrillation. PVI can be done concomitantly with coronary artery bypass grafting, aortic valve replacement for aortic stenosis and combination of them. Procedure is well defined and safe. There is a lack of convincing evidence of the effect on postoperative atrial fibrillation burden, quality of life and symptoms especially in correlation with atrial fibrillation paroxysms.

Conditions

• Paroxysmal Atrial Fibrillation
• Coronary Artery Disease

Interventions

Type	Name	Description
PROCEDURE	CABG, AVR or CABG+AVR and PVI
PROCEDURE	CABG, AVR or CABG+AVR

Timeline

• Start date: 2012-11-01
• Primary completion: 2020-09-01
• Completion: 2020-09-01
• First posted: 2013-02-13
• Last updated: 2020-09-02

Locations

1 site across 1 country: Finland